A Pilot Study to Evaluate Short Term Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinomas in Cosmetically Challenging Locations
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2019
Price : $35 *
At a glance
- Drugs Sonidegib (Primary) ; Imiquimod
- Indications Basal cell cancer
- Focus Therapeutic Use
- Acronyms SONIB
- 03 Oct 2019 Planned End Date changed from 1 Apr 2020 to 1 Dec 2021.
- 03 Oct 2019 Planned primary completion date changed from 1 Nov 2019 to 1 Dec 2020.
- 22 Jul 2019 Status changed from not yet recruiting to recruiting.